Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis
Abstract Background Worse prognosis of endometrial cancers (EC) in tamoxifen‐treated women compared to non‐tamoxifen‐treated women been proposed. The relationship between tamoxifen treatment of breast cancer (BC) and the risk of EC is controversial and there is no agreement between publication resul...
Main Authors: | Matin Ghanavati, Yasaman Khorshidi, Mahdi Shadnoush, Mohammad Esmaeil Akbari, Seyed Hossein Ardehali, Yanin Chavarri‐Guerra, Atieh Akbari, Regina Barragan‐Carrillo, Manoochehr Amin Amlashi, Zeinab Javid, Jamal Rahmani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1806 |
Similar Items
-
Tamoxifen and Endometrial Cancer: A Janus-Headed Drug
by: Günter Emons, et al.
Published: (2020-09-01) -
Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study
by: Ekaterina O. Golubenko, et al.
Published: (2023-05-01) -
Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
by: Atanas Ignatov, et al.
Published: (2020-07-01) -
Effects of tamoxifen-loaded erythropoietin-coated nanostructured lipid carrier on breast cancer cells and rat mammary gland tumour
by: Beh, Chaw Yee
Published: (2019) -
Fabrication, characterization and functionalization of single-walled carbon nanotube conjugated with tamoxifen and its anticancer potential against human breast cancer cells
by: Oskoueian, Arshin
Published: (2018)